Atara Biotherapeutics, Inc. financial data

Symbol
ATRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 105 % -74%
Quick Ratio 8.44 %
Debt-to-equity -418 % -414%
Return On Equity 387 %
Return On Assets -122 % -110%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 119M shares +21.8%
Common Stock, Shares, Outstanding 120M shares +24.6%
Entity Public Float 162M USD -77.4%
Common Stock, Value, Issued 12K USD +20%
Weighted Average Number of Shares Outstanding, Basic 141M shares +35.2%
Weighted Average Number of Shares Outstanding, Diluted 141M shares +35.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 208M USD -19.9%
General and Administrative Expense 48.1M USD -25.8%
Costs and Expenses 58.6M USD -23.1%
Operating Income (Loss) -232M USD +13.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -233M USD -8.45%
Income Tax Expense (Benefit) 17K USD -50%
Net Income (Loss) Attributable to Parent -233M USD -8.44%
Earnings Per Share, Basic -2.12 USD/shares -1.44%
Earnings Per Share, Diluted -2.12 USD/shares -1.44%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 35.1M USD -28%
Accounts Receivable, after Allowance for Credit Loss, Current 35.8M USD +8926%
Inventory, Net 16.1M USD +201%
Other Assets, Current 8.13M USD -36.9%
Assets, Current 106M USD -52.5%
Property, Plant and Equipment, Net 2.99M USD -48.9%
Operating Lease, Right-of-Use Asset 52M USD -20.2%
Other Assets, Noncurrent 3.87M USD -44%
Assets 165M USD -45.3%
Accounts Payable, Current 2.85M USD -43.7%
Employee-related Liabilities, Current 5.71M USD -36%
Accrued Liabilities, Current 18.2M USD +169%
Contract with Customer, Liability, Current 77.8M USD
Liabilities, Current 181M USD +166%
Contract with Customer, Liability, Noncurrent 719K USD -99.1%
Operating Lease, Liability, Noncurrent 42.2M USD -23.2%
Other Liabilities, Noncurrent 4.4M USD -15%
Liabilities 264M USD +11.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -55K USD +95.6%
Retained Earnings (Accumulated Deficit) -2B USD -13.2%
Stockholders' Equity Attributable to Parent -98.3M USD -251%
Liabilities and Equity 165M USD -45.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.6M USD +22.9%
Net Cash Provided by (Used in) Financing Activities 24.1M USD +10173%
Net Cash Provided by (Used in) Investing Activities 14.7M USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 120M shares +24.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 35.2M USD -27.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 114K USD +1.79%
Deferred Tax Assets, Valuation Allowance 475M USD +12.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 487M USD +11.2%
Operating Lease, Liability 57M USD -19.6%
Depreciation 3.7M USD -9.76%
Payments to Acquire Property, Plant, and Equipment 127K USD -68.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -232M USD -8.22%
Lessee, Operating Lease, Liability, to be Paid 74.5M USD -19.9%
Property, Plant and Equipment, Gross 19.7M USD +3.11%
Operating Lease, Liability, Current 13.1M USD +11.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.5M USD +2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 17.2M USD -10.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +20.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17.5M USD -20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17.3M USD -3.41%
Deferred Tax Assets, Operating Loss Carryforwards 324M USD +6.94%
Current Income Tax Expense (Benefit) 15K USD +25%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 160M USD +6.21%
Lessee, Operating Lease, Liability, to be Paid, Year Four 5.76M USD -65.2%
Operating Lease, Payments 16.7M USD +24.2%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 1K USD
Deferred Tax Assets, Net of Valuation Allowance 11.6M USD -23.7%
Share-based Payment Arrangement, Expense 42M USD -18%
Interest Expense 5.1M USD +199%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares